Main Article Content
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allow the author(s) to hold the copyright without restrictions.
- The journal allow the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
2. Thompson JC, Whittaker M. Pseudocholinesterase activity in thyroid disease. J. Clin. Path. 1965;18:811
3. Porter WH. Carl AB, Edward RA editors, Tietz Textbook of clinical chemistry. Clinical Toxicology. 3rd edition, Elsevier Health Sciences. 1999;940.
4. Vlaicu R, Popescu E, Popescu TA, Cucuianu M. Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.Endocrinologie. 1978;16(2):147-51.
5. Sleeba SK, Prasad BNR, Bangera M. Pseudocholinesterase as a biochemical marker in hypothyroidism. Asian J Pharm Clin Res. 2013;16(2):9-20.
6. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 2004; 157-163.
7. Hollander CS. Clinical laboratory observation in cases of T3 toxicosis confirmed by radioimmunoassay. Lancet.1972;1:609-611.
8. Schuurs AHWM and Van Weeman BK. Review Enzyme immunoassay. Clin. Chem. Acta.1977; 81:1
9. Uotila M, Ruoslahti E and Engvall E. J. Immunol. Methods. 1981;42:11-15.
10. Charles h. Sawyer and John W. Everett. Liver synthesis of serum cholinesterase. Am j physiol. 1947;148(3):67583.
11. Allian CC, Poon LS, Chan CSG, Richmond W and Fu P: Enzymatic determination of total serum cholesterol. Clin. Chem 1974; 20: 470.
12. Thompson J.C and Whittakker M. Pseudocholinesterase activity in thyroid disease. J. clin. Path, 1965; 18, 811.